FDA Inspection 1190362 — Cagatay Arslan, M.D.
The FDA completed an inspection of Cagatay Arslan, M.D. on Oct 28, 2022 in Imbatli. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Imbatli (Turkey)
Additional details
Clinical Investigator (CI)